Youth with schizophrenia are at high risk. of diabetes: Opportunities for prevention and early intervention.

Size: px
Start display at page:

Download "Youth with schizophrenia are at high risk. of diabetes: Opportunities for prevention and early intervention."

Transcription

1 Youth with schizophrenia are at high risk of diabetes: Opportunities for prevention and early intervention. Katherine Samaras Department of Endocrinology, St Vincent s Hospital Diabetes and Obesity Program, Garvan Institute of Medical Research Sydney, AUSTRALIA

2 REAL WORLD FAMILY EXPERIENCES: Will my daughter become like the rest of her group? Health trajectories in youth with psychosis 12 kg gain by 12 weeks APM initiation Secondary amenorrhea Acne, hirsutism Interrupted tertiary education

3 if youth with psychosis could expect -to keep the health they currently possess -to develop in education, life skills and fulfilling life experiences -parity of life expectancy These would be ours aims if the diagnosis was type 1 diabetes

4 Mind the life expectancy gap That people with SMI die 20 years earlier.., the majority from preventable causes, is one of the greatest health scandals of our time. Dame Professor Sue Bailey Past President Royal College of Psychiatrists Lawrence et al 2013 BMJ

5 Health trajectories in people with severe mental illness weight gain hyperlipidemia polycystic ovary syndrome diabetes heart disease hypertension cancer

6 The trajectory to poor health: weight gain on APM 20 First episode psychosis Established SMI 15 4 kg 3 kg kg kg Months Alvarez-Jimenez et al; CNS Drugs, 2008 Khan et al, Lancet 2008

7

8 Opportunity #1: Prevent APM-induced weight gain 20 First episode psychosis Established SMI kg Start HERE, 5 NOW! STOP natural history 12 kg 4 kg 3 kg Months Alvarez-Jimenez et al; CNS Drugs, 2008 Khan et al, Lancet 2008

9 The effects of neglect after APM initiation in FEP Weight gain in 60% of treatment-naïve by 2-4 months % after 1-2 years Alvarez-Jimenez, months in APM-naïve youth 4.4kg aripiprazole 8.5kg olanzapine vs 0.2kg weight gain in controls Correll, 2009 weight gain (>7%) by 12 months in APM-naïve olanzapine 86% haloperidol 53% quetiapine 65% ziprasidone37% Kahn, 2008 Rapid onset metabolic abnormalities hyperlipidaemia by 12 weeks Perez-Iglesias, 2007 insulin resistance by 52 weeks Perez-Iglesias, 2009 In healthy volunteers, antipsychotics induced fasting and postprandial hyperinsulinaemia within 12 days Teff, 2013

10

11

12 The Keeping the Body in Mind Program It s simple sharing diabetes prevention principles and expertise with mental health co-workers Address the barriers to healthy lifestyle Weekly individualised counselling: dietitian and exercise physiologist Weekly classes for life-skills training: health coaching cooking shopping Budgeting Daily access to a gym within the FEP Unit Controls: STANDARD CARE: FEP from a demographically matched service Curtis J et al, Early Int Psych 2015:DOI: /eip.12230

13 Who gained >7% baseline weight? 13% 75% P<0.001 Curtis J et al, Early Int Psych 2015:DOI: /eip.12230

14 Never miss an opportunity: weight neutrality APM- induced weight gain can be halted through individualized lifestyle interventions Weight neutrality is a realistic and attainable goal Replication: NHS undertaking studies in collaboration Curtis J et al, Early Int Psych 2015:DOI: /eip.12230

15 Grass roots co-ordinated person-centered care Psychiatrist MH Nurse Family physician Exercise physiologist Endocrinologist Occupational therapist Dietitian

16 Not-so-sweet young things

17 Diabetes & antipsychotic use in children and youth

18 Could diabetes rates be even higher? Ascertainment: diabetes symptoms (symptoms at >300 mg/dl, N<100) need for medication: worst hyperglycaemia Asymptomatic / untreated cases missed No routine glucose screening Likely underestimation Samaras K, Correll C, Mitchell A, De Hert M. JAMA Psych 2014; 71:

19 Medication-associated risk of future diabetes in SMI Antipsychotic medications: 2-5 fold increased risk High rates of undiagnosed diabetes (5-14%) High rates of pre-diabetes (33%) Antidepressants: Double risk for diabetes, even with lifestyle intervention Rubino et al Nurses Health Study: tripled rate Pan et al 2012

20 Missed Opportunity: No blood glucose screening

21 Prevention/Intervention Opportunity 2: glucose screen Pre-diabetes: F. Glucose > 5.5 mmol/l 100 mg/dl Diabetes: F. Glucose > 7.0 mmol/l 126 mg/dl R. glucose > 11.1 mmol/l 200 mg/dl HbA1c > 6.4%

22

23 A sweet calamity synchronous schizophrenia and diabetes Worse control More frequent diabetic complications Worse CV risk factors More frequent amputations Higher rates of non-attendance Evidence of sub-standard care when they do attend Less treatment of CVD risk Less change in glucose lowering medications

24 Challenges in diabetes care Complex disease: highly organized, health-obsessed, adherent do better Costly: medications, monitoring, better foods Accessing the right food: challenges Poor nutritional choices: low quality, cheap foods Food literacy and access to kitchen Accessing physical activity: challenges Am I AWAKE enough? Can I leave home? Paranoia, safety Where do I exercise? Accessing medical care Clinics are in the mornings Clinics are noisy, loud I forgot.. (cognition, sedation) I was treated like a leper (treatment discrimination evidence)

25 Metformin with antipsychotic use MF at initiation olanzepine 15mg N=40, FEP mean age 25y MF after 10% weight gain, various antipsychotics N=128, mean age 26y, 9m schizophrenia Wu RR et al, Am J Psychiatry 2008; 165: Wu RR et al, JAMA 2008; 299:

26 More on metformin Curtis, Newall, Myles, Shiers, Samaras ; 27:

27 HeAL: Healthy Active Lives Jackie Curtis David Shiers Katherine Samaras Philip Ward Mario Alvarez Jimenez Debra Foley Eoin Killackey Stephanie Webster Christoph Correll Davy Vancampfort Richard Holt Jonathan Campion

28 Healthy Active Lives Ambitious 5 year targets The majority of people have: Regular review of medications No more than 7% weight gain Maintain healthy blood glucose, lipids and blood pressure

29 Healing is a matter of time but sometimes also a matter of opportunity Hippocrates

30

31 Physical Fall-out of Anti-psychotic Medications Impacts of physical burden of disease in mental health: Disease in those who are most unable to deal with complex diseases Late presentation Economic costs of: Health, now and the future Lost potential workforce Premature loss of life: OECD

32 Changing our expectations of health in SMI weight gain hyperlipidemia polycystic ovary syndrome diabetes heart disease hypertension cancer

33

34 mmol/l mmol/l mmol/l kg kg/m2 cm Results P<0.001 P<0.001 P<0.001 Weight BMI Waist circumference w 12w KBIM Standard care 10 KBIM Standard care 60 KBIM Standard care Glucose High density lipoprotein Triglycerides KBIM Standard care KBIM Standard care KBIM Standard care Curtis J et al, Early Int Psych 2015:DOI: /eip.12230

35 HeAL Plus International Network Objective: Collect data to record and report physical health» Examine if HeAL Outcome Targets are met Standardized: Sociodemographics Physical and mental health characteristics QoL Physical examination Metabolic and other measures Lifestyle measures Canadian iphys Satellite Symposium: Thursday 21 st May Early Psychosis Intervention Ontario Network (EPION)

36 Future practice in action: international links

37 Are we being honest when we talk about parity? How would we treat the 18 yo girl obese /pre-diabetic/pcos? Metformin use off-label? Evidence in: Pre-diabetes, impaired glucose tolerance, PCOS, obesity, early puberty RCT evidence in psychosis: APM-initiation AND long term

Healthy Active Lives (HeAL)

Healthy Active Lives (HeAL) Healthy Active Lives (HeAL) Keeping the Body in Mind in Youth with Psychosis Imagine a world where Young people experiencing psychosis have the same life expectancy and expectations of life as their peers

More information

Improving cardiometabolic health in people with mental illness & in people with ID AADDM post conference workshop

Improving cardiometabolic health in people with mental illness & in people with ID AADDM post conference workshop Improving cardiometabolic health in people with mental illness & in people with ID AADDM post conference workshop School of Psychiatry Dr Jackie Curtis 1, Dr Carmela Salomon 2, Prof Julian Trollor 2 1

More information

Early Intervention in Psychosis... Dec 7 th Wakefield

Early Intervention in Psychosis... Dec 7 th Wakefield Early Intervention in Psychosis... Dec 7 th Wakefield David.Shiers@doctors.org.uk Declaration of Interest: 1. Member of two Guideline Development Groups (GDG) for NICE: a) NICE guidance for children and

More information

10/08/2015. Overview. The scandal of premature mortality

10/08/2015. Overview. The scandal of premature mortality Improving cardiometabolic health in people with mental illness & in people with ID AADDM post conference workshop School of Psychiatry Dr Jackie Curtis 1, Dr Carmela Salomon 2, Prof Julian Trollor 2 1

More information

Weight Gain and Severe Mental Illness: a Double Blow.

Weight Gain and Severe Mental Illness: a Double Blow. Weight Gain and Severe Mental Illness: a Double Blow. Dr David Shiers GP Advisor National Audit of Schizophrenia Dec 13 th Public Mental Health Seminar Declaration of Interest: Member of two Guideline

More information

Antipsychotic-Related Risk for Weight Gain and Metabolic Abnormalities During Development Christoph U. Correll, MD

Antipsychotic-Related Risk for Weight Gain and Metabolic Abnormalities During Development Christoph U. Correll, MD Antipsychotic-Related Risk for Weight Gain and Metabolic Abnormalities During Development Christoph U. Correll, MD Professor of Psychiatry and Molecular Medicine Hofstra North Shore - LIJ School of Medicine

More information

More than We Bargained For: Metabolic Side Effects of Antipsychotic Medications

More than We Bargained For: Metabolic Side Effects of Antipsychotic Medications More than We Bargained For: Metabolic Side Effects of Antipsychotic Medications Michael D. Jibson, MD, PhD Professor of Psychiatry University of Michigan Disclosure In the past 12 months I have received

More information

The Brain and the Body: Medical Comorbidities in Psychiatric Illness. Kate Miley, CNP Psychiatric Nurse Practitioner, HCMC Adult Psychiatry Clinic

The Brain and the Body: Medical Comorbidities in Psychiatric Illness. Kate Miley, CNP Psychiatric Nurse Practitioner, HCMC Adult Psychiatry Clinic The Brain and the Body: Medical Comorbidities in Psychiatric Illness Kate Miley, CNP Psychiatric Nurse Practitioner, HCMC Adult Psychiatry Clinic The Problem: Health Disparities in SMI Life expectancy

More information

Physical Health Management: Why it s important for adolescents and young adults in mental health services

Physical Health Management: Why it s important for adolescents and young adults in mental health services Physical Health Management: Why it s important for adolescents and young adults in mental health services Early Intervention Service Wellington Lauren Heath and Erin Dawson Introduction Second generation

More information

Minimising the Impact of Medication on Physical Health in Schizophrenia

Minimising the Impact of Medication on Physical Health in Schizophrenia Minimising the Impact of Medication on Physical Health in Schizophrenia John Donoghue Liverpool Imagination is more important than knowledge Albert Einstein LIFESTYLE Making choices TREATMENT Worse Psychopathology,

More information

Michael J. Bailey, M.D. OptumHealth Public Sector

Michael J. Bailey, M.D. OptumHealth Public Sector Michael J. Bailey, M.D. OptumHealth Public Sector LIHP Quality Charter To ensure the quality of care delivered to enrollees in San Diego County Assistance Programs, such as County Medical Services (CMS)

More information

Metabolic Monitoring, Schizophrenia Spectrum Illnesses, & Second Generation Antipsychotics

Metabolic Monitoring, Schizophrenia Spectrum Illnesses, & Second Generation Antipsychotics Metabolic Monitoring, Schizophrenia Spectrum Illnesses, & Second Generation Antipsychotics National Council for Behavioral Health Montefiore Medical Center Northwell Health New York State Office of Mental

More information

Why are NICE guidelines and standards important and relevant to us?

Why are NICE guidelines and standards important and relevant to us? Why are NICE guidelines and standards important and relevant to us? Dr Liz England GP, Laurie Pike health centre RCGP Mental Health Clinical and Commissioning Lead SWB CCG Mental Health Lead NIHR Clinical

More information

Should Psychiatrists be diagnosing (and treating) metabolic syndrome

Should Psychiatrists be diagnosing (and treating) metabolic syndrome Should Psychiatrists be diagnosing (and treating) metabolic syndrome David Hopkins Clinical Director, Diabetes King s College Hospital, London Diabetes prevalence (thousands) Diabetes in the UK: 1995-2010

More information

Diabetes, Diet and SMI: How can we make a difference?

Diabetes, Diet and SMI: How can we make a difference? Diabetes, Diet and SMI: How can we make a difference? Dr. Adrian Heald Consultant in Endocrinology and Diabetes Leighton Hospital, Crewe and Macclesfield Research Fellow, Manchester University Relative

More information

APNA 27th Annual Conference Session 3043: October 11, 2013

APNA 27th Annual Conference Session 3043: October 11, 2013 Development of a Behavioral Health Medical Home: Nurses Filling the Gap Paula Bolton, MS, ANP-BC Margaret Knight, PhD, PMHCNS-BC Catherine Coakley, MS, RN-BC Lynne Kopeski, MSN, PMHCNS-BC Karen Slifka,

More information

Hearts and Minds An ECG Update. Tuesday 18 th November The Met Hotel, Leeds

Hearts and Minds An ECG Update. Tuesday 18 th November The Met Hotel, Leeds Hearts and Minds An ECG Update Tuesday 18 th November The Met Hotel, Leeds Ashleigh Bradley Specialist Clinical Pharmacist for Mental Health and Lithium Clinic Airedale NHS Foundation Trust Introduction

More information

Introduction. Objectives. Psychotropic Medications & Cardiometabolic Risk

Introduction. Objectives. Psychotropic Medications & Cardiometabolic Risk Psychotropic Medications & Cardiometabolic Risk Sam Ellis, PharmD, BCPS, CDE Associate Professor University of Colorado School of Pharmacy Introduction Second GenerationAntipsychotics (SGA) first FDA approved

More information

Double jeopardy: diabetes and severe mental illness. Addressing the special needs of this vulnerable group

Double jeopardy: diabetes and severe mental illness. Addressing the special needs of this vulnerable group Diabetes Management Double jeopardy: diabetes and severe mental illness. Addressing the special needs of this vulnerable group Elizabeth Blanchard 1 & Katherine Samaras*,1,2 Practice points Severe mental

More information

First Episode Schizophrenia

First Episode Schizophrenia First Episode Schizophrenia Abigail Donovan, M.D. Assistant Professor of Psychiatry, Harvard Medical School Director, First Episode and Early Psychosis Program MGH Schizophrenia Program Massachusetts General

More information

Dr Kathy Greenwood & Remy Gray

Dr Kathy Greenwood & Remy Gray Dr Kathy Greenwood & Remy Gray Researchers Remy Grey Serena Gregory Kelly Wilson The Stepwise Team Clinician stepwise therapists Iorwerth John (Worthing ATS) Carrie Marks (Bognor EIP) Lydia Turkson (Crawley

More information

UNDERSTANDING AND MANAGING METABOLIC SYNDROME IN PSYCHIATRY Dr Sanil Rege MBBS, MRCPsych, FRANZCP Consultation-Liaison Psychiatry PaRK MHS, Western

UNDERSTANDING AND MANAGING METABOLIC SYNDROME IN PSYCHIATRY Dr Sanil Rege MBBS, MRCPsych, FRANZCP Consultation-Liaison Psychiatry PaRK MHS, Western UNDERSTANDING AND MANAGING METABOLIC SYNDROME IN PSYCHIATRY Dr Sanil Rege MBBS, MRCPsych, FRANZCP Consultation-Liaison Psychiatry PaRK MHS, Western Australia Talks Facilitator of the CTF Exam Prep Course

More information

The Waypoint Metabolic Clinic for Outpatients

The Waypoint Metabolic Clinic for Outpatients The Waypoint Metabolic Clinic for Outpatients ESTABLISHED IN 2009 TO ADDRESS THE GROWING CO- MORBID INCIDENCE OF METABOLIC SYNDROME IN CLIENTS OF WAYPOINT MENTAL HEALTH CENTRE SUFFERING FROM SERIOUS MENTAL

More information

Objectives. Pre Discussion Question #2. Disparity in Care Demographics

Objectives. Pre Discussion Question #2. Disparity in Care Demographics Objectives Implementation of a pharmacist driven metabolic monitoring protocol for second generation antipsychotics (SGAs) Jonathan Willett, PharmD PGY 1 Pharmacy Practice Resident Chickasaw Nation March

More information

SCHIZOPHRENIA. For Primary Care Providers. Project ECHO LA Adult Psychiatry ECHO June 25, 2014

SCHIZOPHRENIA. For Primary Care Providers. Project ECHO LA Adult Psychiatry ECHO June 25, 2014 SCHIZOPHRENIA For Primary Care Providers Project ECHO LA Adult Psychiatry ECHO June 25, 2014 Curley L. Bonds, MD Medical Director Didi Hirsch Mental Health Services SCHIZOPHRENIA The most common psychotic

More information

Integrating Services To Achieve Better Outcomes In Obesity Management. Dr Nic Kormas FRACP

Integrating Services To Achieve Better Outcomes In Obesity Management. Dr Nic Kormas FRACP Integrating Services To Achieve Better Outcomes In Obesity Management Dr Nic Kormas FRACP Outline Why more resources needed to manage & prevent obesity induced co morbidities Case study demonstrating better

More information

The Metabolic Syndrome Update The Metabolic Syndrome Update. Global Cardiometabolic Risk

The Metabolic Syndrome Update The Metabolic Syndrome Update. Global Cardiometabolic Risk The Metabolic Syndrome Update 2018 Marc Cornier, M.D. Professor of Medicine Division of Endocrinology, Metabolism & Diabetes Anschutz Health and Wellness Center University of Colorado School of Medicine

More information

FL Medicaid Drug Therapy Management Program for Behavioral Health Monitoring for Safety and Quality

FL Medicaid Drug Therapy Management Program for Behavioral Health Monitoring for Safety and Quality FL Medicaid Drug Therapy Management Program for Behavioral Health Monitoring for Safety and Quality April 23, 2014 Pensacola, FL Presentation Objectives To briefly describe the program and how its components

More information

Optimizing risk assessment of total cardiovascular risk What are the tools? Lars Rydén Professor Karolinska Institutet Stockholm, Sweden

Optimizing risk assessment of total cardiovascular risk What are the tools? Lars Rydén Professor Karolinska Institutet Stockholm, Sweden Optimizing risk assessment of total cardiovascular risk What are the tools? Lars Rydén Professor Karolinska Institutet Stockholm, Sweden Cardiovascular Disease Prevention (CVD) Three Strategies for CVD

More information

Collaborating, Co-managing and Facilitating Metabolic Improvement in Patients with Severe Mental Illness (SMI)

Collaborating, Co-managing and Facilitating Metabolic Improvement in Patients with Severe Mental Illness (SMI) Collaborating, Co-managing and Facilitating Metabolic Improvement in Patients with Severe Mental Illness (SMI) 14 th Canadian Collaborative Mental Health Care Conference Montréal, Québec June 28, 2013

More information

University of Groningen. Metabolic risk in people with psychotic disorders Bruins, Jojanneke

University of Groningen. Metabolic risk in people with psychotic disorders Bruins, Jojanneke University of Groningen Metabolic risk in people with psychotic disorders Bruins, Jojanneke IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from

More information

Objectives. Disclosure of Commercial Support. Psychopharmacology and Pediatric Obesity

Objectives. Disclosure of Commercial Support. Psychopharmacology and Pediatric Obesity Psychopharmacology and Pediatric Obesity Raise awareness of the complex interplay between mental illness and obesity/metabolic disturbances in children Dina Panagiotopoulos, MD, FRCPC Clinical Professor

More information

Physical health assessment and monitoring in long-term mental health care

Physical health assessment and monitoring in long-term mental health care Physical health assessment and monitoring in long-term mental health care Dr Alan Farmer Consultant Psychiatrist Worcestershire Mental Health Partnership NHS Trust A brief questionnaire Current thoughts,

More information

POLYCYSTIC OVARIAN SYNDROME Laura Tatpati, MD Reproductive Endocrinology and Infertility. Based on: ACOG No. 108 Oct 2009; reaffirmed 2015

POLYCYSTIC OVARIAN SYNDROME Laura Tatpati, MD Reproductive Endocrinology and Infertility. Based on: ACOG No. 108 Oct 2009; reaffirmed 2015 POLYCYSTIC OVARIAN SYNDROME Laura Tatpati, MD Reproductive Endocrinology and Infertility Based on: ACOG No. 108 Oct 2009; reaffirmed 2015 NO DISCLOSURES PATIENT 26 years old presents with complaint of

More information

The prevalence of many physical illnesses is increased

The prevalence of many physical illnesses is increased Cardiovascular disease and diabetes in people with severe mental illness: causes, consequences and pragmatic management RICHARD IG HOLT The prevalence of many physical illnesses is increased in people

More information

Case study: Adult with uncontrolled type 2 diabetes of long duration and cardiovascular disease

Case study: Adult with uncontrolled type 2 diabetes of long duration and cardiovascular disease Case study: Adult with uncontrolled type 2 diabetes of long duration and cardiovascular disease Authored by Paul Zimmet and Richard Nesto on behalf of the Global Partnership for Effective Diabetes Management.

More information

BGS Falls Severe mental illness, poor bone health and falls: The potential role for physical activity

BGS Falls Severe mental illness, poor bone health and falls: The potential role for physical activity Severe mental illness, poor bone health and falls: The potential role for physical activity Brendon Stubbs MCSP, PhD Head of Physiotherapy South London and Maudsley NHS Foundation Trust Post Doctoral Research

More information

Medication Audit Checklist- Antipsychotics - Atypical

Medication Audit Checklist- Antipsychotics - Atypical Medication Audit checklist Page 1 of 7 10-2018 Audit number: Client number: Ordering Provider: INDICATIONS 1) Disorders with psychotic symptoms (schizophrenia, schizoaffective disorder, manic disorders,

More information

In recent years, reports of diabetes, diabetic

In recent years, reports of diabetes, diabetic A REVIEW OF METABOLIC ISSUES IN ATYPICAL ANTIPSYCHOTIC TREATMENT John W. Newcomer, MD, * and Henry A. Nasrallah, MD ABSTRACT Reports of diabetes, diabetic ketoacidosis, hyperglycemia, and dyslipidemias

More information

Accessibility and quality of mental health services in rural and remote Australia

Accessibility and quality of mental health services in rural and remote Australia Exercise & Sports Science Australia submission to the Senate Standing Committees on Community Affairs Accessibility and quality of mental health services in rural and remote Australia Alex Lawrence Policy

More information

Comparative incidence of metabolic syndrome in patients with schizophrenia. being treated with second generation antipsychotics vs.

Comparative incidence of metabolic syndrome in patients with schizophrenia. being treated with second generation antipsychotics vs. Comparative incidence of metabolic syndrome in patients with schizophrenia being treated with second generation antipsychotics vs. first generation antipsychotics: A Systematic Review of Literature By

More information

Common Diabetes-related Terms

Common Diabetes-related Terms Common Diabetes-related Terms A1C An A1C test measures a person's average blood glucose level over two to three months. Hemoglobin is the part of a red blood cell that carries oxygen to the cells and sometimes

More information

Cardiometabolic Risk in Patients With First-Episode Schizophrenia Spectrum Disorders Baseline Results From the RAISE-ETP Study

Cardiometabolic Risk in Patients With First-Episode Schizophrenia Spectrum Disorders Baseline Results From the RAISE-ETP Study Research Original Investigation Cardiometabolic Risk in Patients With First-Episode Schizophrenia Spectrum Disorders Baseline Results From the RAISE-ETP Study Christoph U. Correll, MD; Delbert G. Robinson,

More information

THE EVOLUTION OF MAN homo lethargicus gigantico

THE EVOLUTION OF MAN homo lethargicus gigantico THE EVOLUTION OF MAN homo lethargicus gigantico Weight Gain and Metabolic Abnormalities in Patients with Schizophrenia Leslie Citrome, MD, MPH Clinical Professor of Psychiatry and Behavioral Sciences New

More information

Meccanismi fisiopatologici e trattamento dei disturbi metabolici in soggetti affetti da disturbo mentale grave

Meccanismi fisiopatologici e trattamento dei disturbi metabolici in soggetti affetti da disturbo mentale grave Meccanismi fisiopatologici e trattamento dei disturbi metabolici in soggetti affetti da disturbo mentale grave Francesco Bartoli, MD, PhD Università degli Studi di Milano Bicocca Ospedale San Gerardo di

More information

Diabetes: Staying Two Steps Ahead. The prevalence of diabetes is increasing. What causes Type 2 diabetes?

Diabetes: Staying Two Steps Ahead. The prevalence of diabetes is increasing. What causes Type 2 diabetes? Focus on CME at the University of University Manitoba of Manitoba : Staying Two Steps Ahead By Shagufta Khan, MD; and Liam J. Murphy, MD The prevalence of diabetes is increasing worldwide and will double

More information

Diabetes Prevention in. Massachusetts: Prediabetes and the Diabetes Prevention Program. Diabetes Prevention and Control

Diabetes Prevention in. Massachusetts: Prediabetes and the Diabetes Prevention Program. Diabetes Prevention and Control Diabetes Prevention in r Massachusetts: Prediabetes and the Diabetes Prevention Program Diabetes Prevention and Control www.mass.gov/dph/diabetes Massachusetts Department of Public Health 29 million with

More information

Screening for the metabolic syndrome in patients receiving antipsychotic treatment: a proposed algorithm

Screening for the metabolic syndrome in patients receiving antipsychotic treatment: a proposed algorithm Screening for the metabolic syndrome in patients receiving antipsychotic treatment: a proposed algorithm Anna J Waterreus and Jonathan D E Laugharne In 2001, the University of Western Australia s Centre

More information

Dr Aftab Ahmad Consultant Diabetologist at Royal Liverpool University Hospital Regional Diabetes Network Lead

Dr Aftab Ahmad Consultant Diabetologist at Royal Liverpool University Hospital Regional Diabetes Network Lead Dr Aftab Ahmad Consultant Diabetologist at Royal Liverpool University Hospital Regional Diabetes Network Lead Today s Presentation HbA1c & diagnosing Diabetes What is Impaired Glucose & IGR? Implications

More information

Use of Psychotherapeutic Medications in Children and Adolescents with ASD and ID

Use of Psychotherapeutic Medications in Children and Adolescents with ASD and ID Use of Psychotherapeutic Medications in Children and Adolescents with ASD and ID Although not considered first line treatment in children with ASD and ID, depending on the severity of symptoms, some medications

More information

Pharmacotherapy of psychosis and schizophrenia in youth

Pharmacotherapy of psychosis and schizophrenia in youth Pharmacotherapy of psychosis and schizophrenia in youth Benedetto Vitiello Pavia, 2 December 2017 Disclosure Benedetto Vitiello, M.D. Professor of Child and Adolescent Neuropsychiatry University of Turin,

More information

28-Aug-15. RACGP guidelines 2014/15. ADS guidelines Part 1 T2D Guidelines. Part 2 What comes after metformin?

28-Aug-15. RACGP guidelines 2014/15. ADS guidelines Part 1 T2D Guidelines. Part 2 What comes after metformin? Part 1 T2D Guidelines Oral therapies in T2 diabetes Dr Gary Kilov T2D Guidelines - What s New? What comes after metformin? 1 RACGP guidelines 2014/15 ADA-EASD: Anti-Hyperglycaemic therapy 2015 3 4 Inzucchi

More information

Promoting and Monitoring Evidenced-Based Antipsychotic Prescribing Practices in Children and Adolescents: Florida Medicaid Initiatives

Promoting and Monitoring Evidenced-Based Antipsychotic Prescribing Practices in Children and Adolescents: Florida Medicaid Initiatives Promoting and Monitoring Evidenced-Based Antipsychotic Prescribing Practices in Children and Adolescents: Florida Medicaid Initiatives Mary Elizabeth Jones, Pharm BSc, RPh Senior Pharmacist AHCA Pharmacy

More information

University of Groningen

University of Groningen University of Groningen A 12-month follow-up study of treating overweight schizophrenic patients with aripiprazole Schorr, S. G.; Slooff, C. J.; Postema, R.; Van Oven, W.; Schilthuis, M.; Bruggeman, Richard;

More information

Why Do We Care About Prediabetes?

Why Do We Care About Prediabetes? Why Do We Care About Prediabetes? Complications of Diabetes Diabetic Retinopathy Leading cause of blindness in adults 1,2 Diabetic Nephropathy Leading cause of Kidney failure Stroke 2- to 4-fold increase

More information

Metabolic Syndrome Across the Life Cycle - Adolescent. Joy Friedman MD

Metabolic Syndrome Across the Life Cycle - Adolescent. Joy Friedman MD Metabolic Syndrome Across the Life Cycle - Adolescent Joy Friedman MD Disclosures I have no actual or potential conflict of interest in relation to this program or presentation. I will mention off-label

More information

Taking Care: Child and Youth Mental Health PSYCHOSIS TREATMENT OPTIONS

Taking Care: Child and Youth Mental Health PSYCHOSIS TREATMENT OPTIONS Taking Care: Child and Youth Mental Health PSYCHOSIS TREATMENT OPTIONS Open Learning Agency 2004 TREATMENT OPTIONS Psychosis is highly treatable, especially if caught early. The prognosis for recovery

More information

Prevalence of Polycystic Ovarian Syndrome among urban adolescent girls and young women in Mumbai

Prevalence of Polycystic Ovarian Syndrome among urban adolescent girls and young women in Mumbai Prevalence of Polycystic Ovarian Syndrome among urban adolescent girls and young women in Mumbai Principal Investigator Co- Investigators Consultant Collaborating Hospital Dr. Beena Joshi Dr. Srabani Mukherji

More information

Diabetes Mellitus: A Cardiovascular Disease

Diabetes Mellitus: A Cardiovascular Disease Diabetes Mellitus: A Cardiovascular Disease Nestoras Mathioudakis, M.D. Assistant Professor of Medicine Division of Endocrinology, Diabetes, & Metabolism September 30, 2013 1 The ABCs of cardiovascular

More information

Type 2 Diabetes. Stopping Smoking. Consider referral to smoking cessation. Consider referring for weight management advice.

Type 2 Diabetes. Stopping Smoking. Consider referral to smoking cessation. Consider referring for weight management advice. Type 2 Diabetes Stopping Smoking Consider referral to smoking cessation BMI > 25 kg m² Set a weight loss target of a 5-10% reduction Consider referring for weight management advice Control BP to

More information

ESSENTIAL SHARED CARE AGREEMENT FOR Risperidone, Olanzapine, Quetiapine, Aripiprazole, Amisulpride (South Staffordshire Only)

ESSENTIAL SHARED CARE AGREEMENT FOR Risperidone, Olanzapine, Quetiapine, Aripiprazole, Amisulpride (South Staffordshire Only) E099 ESSENTIAL SHARED CARE AGREEMENT FOR Risperidone, Olanzapine, Quetiapine, Aripiprazole, Amisulpride (South Staffordshire Only) NOTE: Please complete details on P1 &3 Send one copy to GP, Patient and

More information

Pre Diabetes Screening in Primary Care

Pre Diabetes Screening in Primary Care University of San Diego Digital USD Doctor of Nursing Practice Final Manuscripts Theses and Dissertations Spring 5-21-2016 Pre Diabetes Screening in Primary Care Christine Rieger crieger@sandiego.edu Follow

More information

Diabetes Guidelines in View of Recent Clinical Trials Are They Still Applicable?

Diabetes Guidelines in View of Recent Clinical Trials Are They Still Applicable? Diabetes Guidelines in View of Recent Clinical Trials Are They Still Applicable? Jay S. Skyler, MD, MACP Division of Endocrinology, Diabetes, and Metabolism and Diabetes Research Institute University of

More information

How Good a Doctor? Physical Health Care in a Forensic Setting. Dr. Alan Cohen FRCGP

How Good a Doctor? Physical Health Care in a Forensic Setting. Dr. Alan Cohen FRCGP How Good a Doctor? Physical Health Care in a Forensic Setting Dr. Alan Cohen FRCGP Director of Primary Retired Care, West Grumpy London Old Git Mental Health Trust Take Diabetes More common in people

More information

Implementation of Performance Improvement Projects

Implementation of Performance Improvement Projects Implementation of Performance Improvement Projects Mary Marlatt-Dumas, Quality Manager, NMRE, Region 2 Diane L. Bennett, QI Coordinator/Compliance Officer, NorthCare Network, Region 1 Bill Phelps, Quality

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Larsen JR, Vedtofte L, Jakobsen MSL, et al. Effect of liraglutide treatment on prediabetes and overweight or obesity in clozapine- or olanzapine-treated patients with schizophrenia

More information

PRIMARY CARE MANAGEMENT OF OBESITY

PRIMARY CARE MANAGEMENT OF OBESITY Psychiatry and Addictions Case Conference UW Medicine Psychiatry and Behavioral Sciences PRIMARY CARE MANAGEMENT OF OBESITY LYDIA CHWASTIAK MD, MPH ASSOCIATE PROFESSOR UNIVERSITY OF WASHINGTON DEPARTMENT

More information

Cardiometabolic Side Effects of Risperidone in Children with Autism

Cardiometabolic Side Effects of Risperidone in Children with Autism Cardiometabolic Side Effects of Risperidone in Children with Autism Susan J. Boorin, MSN, PMHNP-BC PhD Candidate Yale School of Nursing 1 This speaker has no conflicts of interest to disclose. 2 Boorin

More information

Treatment of Schizophrenia Appendix Three Page 1 of 8

Treatment of Schizophrenia Appendix Three Page 1 of 8 Prescribing Guidelines Treatment of Schizophrenia Scope of this guidance This guidance aims to describe the pharmacological management of schizophrenia at a simple and intermediate level, with a brief

More information

Office of Health Equity Advisory Committee Meeting

Office of Health Equity Advisory Committee Meeting Office of Health Equity Advisory Committee Meeting Disparities in Mental Health Status and Care Sergio Aguilar-Gaxiola, MD, PhD Professor of Clinical Internal Medicine Director, Center for Reducing Health

More information

Metabolic Syndrome Update The Metabolic Syndrome: Overview. Global Cardiometabolic Risk

Metabolic Syndrome Update The Metabolic Syndrome: Overview. Global Cardiometabolic Risk Metabolic Syndrome Update 21 Marc Cornier, M.D. Associate Professor of Medicine Division of Endocrinology, Metabolism & Diabetes University of Colorado Denver Denver Health Medical Center The Metabolic

More information

Screening and Diagnosis of Diabetes Mellitus in Taiwan

Screening and Diagnosis of Diabetes Mellitus in Taiwan Screening and Diagnosis of Diabetes Mellitus in Taiwan Hung-Yuan Li, MD, MMSc, PhD Attending Physician, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan Associate Professor,

More information

Why is Earlier and More Aggressive Treatment of T2 Diabetes Better?

Why is Earlier and More Aggressive Treatment of T2 Diabetes Better? Blood glucose (mmol/l) Why is Earlier and More Aggressive Treatment of T2 Diabetes Better? Disclosures Dr Kennedy has provided CME, been on advisory boards or received travel or conference support from:

More information

Mental Health Clinical Pathways Group. The Case for Change

Mental Health Clinical Pathways Group. The Case for Change Mental Health Clinical Pathways Group The Case for Change Contents 1. Executive summary 2. Introduction 2.1. What is severe mental illness? 2.2. Findings of the Disability Rights Commission 3. Physical

More information

Metabolic Syndrome: A Preventable & Treatable Cluster of Conditions

Metabolic Syndrome: A Preventable & Treatable Cluster of Conditions Metabolic Syndrome: A Preventable & Treatable Cluster of Conditions April D. McNeill MD Candidate 2016, Southern Illinois University, School of Medicine GE-NMF Primary Care Leadership Program, July 2013

More information

Hospital Authority Convention 2010 Presented by : Dr Cheng Ming Kin Medical Officer,Department of Medicine Tseung Kwan O Hospital

Hospital Authority Convention 2010 Presented by : Dr Cheng Ming Kin Medical Officer,Department of Medicine Tseung Kwan O Hospital Hospital Authority Convention 2010 Prevalence of Cardiovascular Risk Factors, the Metabolic Syndrome and the 10-year risk for Coronary Heart Disease in the Staff of Tseung Kwan O Hospital Presented by

More information

Schizophrenia: Treating The Whole Person

Schizophrenia: Treating The Whole Person Schizophrenia: Treating The Whole Person Jacob S. Ballon, M.D., M.P.H & Douglas L. Noordsy, M.D. INSPIRE Clinic PEPPNET Prodrome and Early Psychosis Program NETwork Stanford University Department of Psychiatry

More information

Reducing risk in heart disease

Reducing risk in heart disease Reducing risk in heart disease An expert guide to clinical practice for secondary prevention of coronary heart disease Prof Patricia Davidson (chair) Prof Nigel Stocks Dr Anu Aggarwal Ms Jill Waddell Ms

More information

Fidelity and Outcomes in Community Care

Fidelity and Outcomes in Community Care Faculty Disclosure Alex Kopelowicz, MD Dr. Kopelowicz has listed no financial interest/arrangement that would be considered a conflict of interest. Fidelity and Outcomes in Community Care Alex Kopelowicz,

More information

ESSENTIAL SHARED CARE AGREEMENT FOR Risperidone, Olanzapine, Quetiapine, Aripiprazole, Amisulpride or Asenapine

ESSENTIAL SHARED CARE AGREEMENT FOR Risperidone, Olanzapine, Quetiapine, Aripiprazole, Amisulpride or Asenapine Ref No: E053 ESSENTIAL SHARED CARE AGREEMENT FOR Risperidone, Olanzapine, Quetiapine, Aripiprazole, Amisulpride or Asenapine NOTE: Please complete details on P1 &3 Send one copy to GP, Patient and file

More information

Secondary prevention and systems approaches: Lessons from EUROASPIRE and EUROACTION

Secondary prevention and systems approaches: Lessons from EUROASPIRE and EUROACTION Secondary prevention and systems approaches: Lessons from EUROASPIRE and EUROACTION Dr Kornelia Kotseva National Heart & Lung Insitute Imperial College London, UK on behalf of all investigators participating

More information

SCHIZOPHRENIA IS COGNITION IMPAIRED IN SCHIZOPHRENIA?

SCHIZOPHRENIA IS COGNITION IMPAIRED IN SCHIZOPHRENIA? CHAPTER 10: DISTURBED COGNITION IN SCHIZOPHRENIA Traditionally, functioning of the mind is described under four headings: perception, emotion, cognition, and conation. Perception refers to awareness of

More information

The Metabolic Syndrome: Is It A Valid Concept? YES

The Metabolic Syndrome: Is It A Valid Concept? YES The Metabolic Syndrome: Is It A Valid Concept? YES Congress on Diabetes and Cardiometabolic Health Boston, MA April 23, 2013 Edward S Horton, MD Joslin Diabetes Center Harvard Medical School Boston, MA

More information

Prevalence of Metabolic Syndrome in Psychiatric Outpatients in a Tertiary Care Hospital, Kerala.

Prevalence of Metabolic Syndrome in Psychiatric Outpatients in a Tertiary Care Hospital, Kerala. Indian Journal of Pharmacy Practice Association of Pharmaceutical Teachers of India Prevalence of Metabolic Syndrome in Psychiatric Outpatients in a Tertiary Care Hospital, Kerala. 1 3 Linu Mohan P*, Jishnu

More information

Pre-diabetes. Pharmacological Approaches to Delay Progression to Diabetes

Pre-diabetes. Pharmacological Approaches to Delay Progression to Diabetes Pre-diabetes Pharmacological Approaches to Delay Progression to Diabetes Overview Definition of Pre-diabetes Risk Factors for Pre-diabetes Clinical practice guidelines for diabetes Management, including

More information

Re: Safety data on Zyprexa (olanzapine) and Symbyax (olanzapine and fluoxetine HCl capsules) Hyperglycemia, Weight Gain, and Hyperlipidemia

Re: Safety data on Zyprexa (olanzapine) and Symbyax (olanzapine and fluoxetine HCl capsules) Hyperglycemia, Weight Gain, and Hyperlipidemia www.lilly.com Eli Lilly and Company Lilly Corporate Center Indianapolis, Indiana 46285 U.S.A. Phone 317 276 2000 October 5, 2007 Re: Safety data on Zyprexa (olanzapine) and Symbyax (olanzapine and fluoxetine

More information

National Academy of Science July 17-18, 2018 Washington DC Larry Alphs, MD, PhD RESTRICTION OF TREATMENT QUALITY IN PRAGMATIC CLINICAL TRIALS

National Academy of Science July 17-18, 2018 Washington DC Larry Alphs, MD, PhD RESTRICTION OF TREATMENT QUALITY IN PRAGMATIC CLINICAL TRIALS National Academy of Science July 17-18, 2018 Washington DC Larry Alphs, MD, PhD RESTRICTION OF TREATMENT QUALITY IN PRAGMATIC CLINICAL TRIALS Key Points for RWE in Randomized Clinical Trials What is the

More information

ARE YOU PRE-DIABETIC?

ARE YOU PRE-DIABETIC? hclhealthcare.in ARE YOU PRE-DIABETIC? Read on to find out. 1800 103 7070 FOR APPOINTMENT If a blood test shows that a person's blood sugar is higher than normal but not high enough to be called Diabetes,

More information

Metabolic Syndrome. Shon Meek MD, PhD Mayo Clinic Florida Endocrinology

Metabolic Syndrome. Shon Meek MD, PhD Mayo Clinic Florida Endocrinology Metabolic Syndrome Shon Meek MD, PhD Mayo Clinic Florida Endocrinology Disclosure No conflict of interest No financial disclosure Does This Patient Have Metabolic Syndrome? 1. Yes 2. No Does This Patient

More information

Curr Opin Psychiatry 21: ß 2008 Wolters Kluwer Health Lippincott Williams & Wilkins

Curr Opin Psychiatry 21: ß 2008 Wolters Kluwer Health Lippincott Williams & Wilkins Addressing cardiometabolic risk during treatment with antipsychotic medications Jonathan M. Amiel a,b, Christina V. Mangurian a,b, Rohan Ganguli c,d and John W. Newcomer e a Columbia University College

More information

EARLY ONSET SCHIZOPHRENIA

EARLY ONSET SCHIZOPHRENIA Psychiatry and Addictions Case Conference UW Medicine Psychiatry and Behavioral Sciences EARLY ONSET SCHIZOPHRENIA JON MCCLELLAN CHILD STUDY AND TREATMENT CENTER GENERAL DISCLOSURES The University of Washington

More information

Practical Psychopharmacology for More Complex Mental Health Presentations

Practical Psychopharmacology for More Complex Mental Health Presentations MINISTRY OF CHILDREN AND YOUTH SERVICES Practical Psychopharmacology for More Complex Mental Health Presentations Part 2: Antipsychotics & Mood Stabilizers Dr. Ajit Ninan & Joel Lamoure 1 : Who are we?

More information

Client Report Screening Program Results For: Missouri Western State University October 28, 2013

Client Report Screening Program Results For: Missouri Western State University October 28, 2013 Client Report For: Missouri Western State University October 28, 2013 Executive Summary PROGRAM OVERVIEW From 1/1/2013-9/30/2013, Missouri Western State University participants participated in a screening

More information

Platforms for Performance: Clinical Dashboards to Improve Quality and Safety 2011 Midyear Clinical Meeting

Platforms for Performance: Clinical Dashboards to Improve Quality and Safety 2011 Midyear Clinical Meeting Improving Mental Health Outcomes in Veterans Through Dashboard Technology Learning Objectives 1. Describe VA Academic Detailing 2. Show how an increase in metabolic monitoring and a decrease in off-label

More information

Community Based Diabetes Prevention

Community Based Diabetes Prevention Community Based Diabetes Prevention Melanie Davies Professor of Diabetes Medicine Outline NIHR Programme Grant proposal and update to progress The Vascular Check programme HbA1c debate Algorithm to detect

More information

Datix Ref:

Datix Ref: Title Document Details Shared Care Agreement: Antipsychotics (Risperidone, Olanzapine, Quetiapine, Aripiprazole, Amisulpride or Asenapine) Trust Ref No 2081-38933 Local Ref (optional) Main points the document

More information

Objectives 10/11/2013. Diabetes- The Real Cost of Sugar. Diabetes 101: What is Diabetes. By Ruth Nekonchuk RD CDE LMNT

Objectives 10/11/2013. Diabetes- The Real Cost of Sugar. Diabetes 101: What is Diabetes. By Ruth Nekonchuk RD CDE LMNT Diabetes- The Real Cost of Sugar By Ruth Nekonchuk RD CDE LMNT Objectives To explain diabetes To explain the risks of diabetes To enumerate the cost of diabetes to our country To enumerate the cost of

More information

Preventing type 2 diabetes the NDH Care Call Service

Preventing type 2 diabetes the NDH Care Call Service Preventing type 2 diabetes the NDH Care Call Service Diabetes Care Call Team 0161 206 5668 All Rights Reserved 2017. Document for issue as handout. Unique Identifier: MED35(17). Review date: July 2019

More information

Diabetes: Across the Lifespan Friday, October 17, Obesity, Insulin Resistance and Type 2 Diabetes Cardiovascular Risks in Children.

Diabetes: Across the Lifespan Friday, October 17, Obesity, Insulin Resistance and Type 2 Diabetes Cardiovascular Risks in Children. Diabetes: Across the Lifespan Friday, October 17, 2014 Obesity, Insulin Resistance and Type 2 Diabetes Cardiovascular Risks in Children. Don P. Wilson, M.D., FNLA Diplomate, Am Brd of Clinical Lipidology

More information

OCCG SERVICE SPECIFICATION (2018/19) Improving Physical Health in Patients with a Severe Mental Illness

OCCG SERVICE SPECIFICATION (2018/19) Improving Physical Health in Patients with a Severe Mental Illness OCCG SERVICE SPECIFICATION (2018/19) Improving Physical Health in Patients with a Severe Mental Illness People living with severe mental illness (SMI) face one of the greatest health inequality gaps in

More information